I am an epidemiologist and a biostatistician, specializing in genetic and molecular approaches to hematologic malignancies. My work focuses on lymphoma and related precursor conditions, integrating genome wide association studies (GWAS), tumor sequencing, and population based epidemiology to study susceptibility, progression, and outcomes.
I completed my PhD in Epidemiology and Biostatistics at the Hebrew University of Jerusalem, where I investigated environmental, infectious, and genetic risk factors for B cell non Hodgkin lymphoma in Jewish and Arab populations. I then conducted postdoctoral research at the Mayo Clinic (Rochester, MN), where I later held the rank of Assistant Professor of Epidemiology. My projects there involved the development of inherited and tumor based genetic scores for prediction models, and I continue to collaborate closely with the Mayo Clinic from the University of Haifa.
I established the Genetic and Molecular Epidemiology Laboratory at the University of Haifa, where we manage biospecimen collections, conduct large scale analyses, and train graduate students in genetic epidemiology, and population based research.
I have been an active member of the International Lymphoma Epidemiology (InterLymph) Consortium since 2016. In 2022, I was elected to the InterLymph Coordinating Committee, and I served as Chair of the Coordinating Committee in 2025. In this role, I led collaborative analyses across more than 20 international studies. Following the completion of my term on the Coordinating Committee, I remain actively involved in consortium initiatives.
I am committed to inclusion of ethnically diverse populations in lymphoma research, particularly by expanding representation of Jewish and Arab populations in international studies. I also supervise patient centered projects, including work on gender differences in quality of life among individuals with CLL and a family based MBL study aimed at reducing anxiety and informing future clinical guidelines.